Kreioglim PM 2mg/500mg/15mg Tablet
Marketer
Kreios Laboratries Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Kreioglim PM 2mg/500mg/15mg Tablet
Glimepiride-Metformin-Pioglitazone 2mg/500mg/15mg tablets are a triple-combination medication managing blood glucose. This therapy, used alongside diet and exercise, enhances blood sugar regulation in adult type 2 diabetics. It improves insulin efficiency, subsequently reducing blood glucose. Dosage and duration for Glimepiride-Metformin-Pioglitazone 2mg/500mg/15mg tablets should strictly follow your physician's instructions. Ingestion with food mitigates stomach discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the usual regimen. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic drugs, alcohol, or skipped meals elevates hypoglycemia risk. Regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions necessitate informing your doctor before commencing treatment. Pregnant or lactating individuals require physician consultation. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption to minimize side effect risk.
Primary Ingredients of Kreioglim PM 2mg/500mg/15mg Tablet
No text provided to rephrase.
Uses of Kreioglim PM 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Kreioglim PM 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Kreioglim PM 2mg/500mg/15mg Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with a meal.
Common Side effects of Kreioglim PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Kreioglim PM 2mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Kreioglim PM 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing. Consume with food.
How Kreioglim PM 2mg/500mg/15mg Tablet works:
Kreioglim PM 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Kreioglim PM 2mg/500mg/15mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Kreioglim PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Kreioglim PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Kreioglim PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical consultation is necessary. This medication is contraindicated for those with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Kreioglim PM 2mg/500mg/15mg tablets, potentially requiring dosage modification under medical supervision. The use of Kreioglim PM 2mg/500mg/15mg tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Kreioglim PM 2mg/500mg/15mg Tablet :
Should you forget a Kreioglim PM 2mg/500mg/15mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Kreioglim PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently